NIAID grant funds new disease research centers

FRAMINGHAM (10/22/2003) - Eight new Regional Centers of Excellence (RCEs) for Biodefense and Emerging Infectious Diseases Research are in the works, thanks to US$350 million in grants from the U.S. National Institute of Allergy and Infectious Diseases (NIAID). NIAID will distribute the grant over five years and administer the nationwide group of multidisciplinary research centers that will study both bioterrorism agents and naturally occurring infectious diseases, such as West Nile virus and drug-resistant pathogens. Each RCE will comprise a lead institution and affiliated institutions in the same geographical region. The eight lead institutions are Duke University; Harvard Medical School; The University of Chicago; University of Maryland at Baltimore; The University of Texas Medical Branch; University of Washington at Seattle; Washington University in St. Louis; and the New York State Department of Health.

Join the newsletter!


Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.

Membership is free, and your security and privacy remain protected. View our privacy policy before signing up.

Error: Please check your email address.

More about Department of Health

Show Comments